{"title":"New multifunctional hybrids as modulators of apoptosis markers and topoisomerase II in breast cancer therapy: synthesis, characterization, and in vitro and in silico studies","link":"http://pubs.rsc.org/en/Content/ArticleLanding/2024/RA/D4RA04219K","date":null,"content":"<div><p><img src=\"/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D4RA04219K\" /></p></div><div><i><b>RSC Adv.</b></i>, 2024, <b>14</b>,28555-28568<br /><b>DOI</b>: 10.1039/D4RA04219K, Paper</div><div><img alt=\"Open Access\" src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png\" /> Open Access</div><div><a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\"> <img src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png\" alt=\"Creative Commons Licence\" /></a>Â  This article is licensed under a <a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\">Creative Commons Attribution-NonCommercial 3.0 Unported Licence.</a></div><div>Heba W. Alhamdi, Mohammad Y. Alfaifi, Ali A. Shati, Serag Eldin I. Elbehairi, Mohammed Er-rajy, Reda F. M. Elshaarawy, Yasser A. Hassan, Rozan Zakrya<br />Recently, molecular hybrids of two or more active pharmacophores have shown promise for designing and synthesizing anticancer drugs.<br />The content of this RSS Feed (c) The Royal Society of Chemistry</div>","author":"","siteTitle":"RSC - RSC Adv. latest articles","siteHash":"da3e282678330308414c63a405ade89dd3738fcce2936ca8a2fe3a6d7e967d99","entryHash":"ae27c272bcf5c320e97371ac5d089b90c10394efea1d6bf0b17a780d1eeb6fe6","category":"Environment"}